Terushige Iike
Corporate Officer/Principal bij EISAI CO., LTD.
Actieve functies van Terushige Iike
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| EISAI CO., LTD. | Corporate Officer/Principal | 01-04-1986 | - |
Loopbaan van Terushige Iike
Eerdere bekende functies van Terushige Iike
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
H3 Biomedicine, Inc.
 H3 Biomedicine, Inc. Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., H3 Biomedicine, Inc. is a precision oncology research and development subsidiary based in Cambridge, MA. The company is uniquely positioned to integrate real-world clinical evidence with the latest advances in cancer genomics. H3 is developing a pipeline of highly targeted, breakthrough medicines that have the potential to impact the future of cancer care and treatment. The CEO of the company is Takashi Owa. | Directeur/Bestuurslid | 01-05-2018 | - |
| Algemeen Directeur | 01-05-2018 | - |
Statistieken
Internationaal
| Japan | 2 |
| Verenigde Staten | 2 |
Operationeel
| Corporate Officer/Principal | 1 |
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
Sectoraal
| Health Technology | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| EISAI CO., LTD. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
H3 Biomedicine, Inc.
H3 Biomedicine, Inc. Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., H3 Biomedicine, Inc. is a precision oncology research and development subsidiary based in Cambridge, MA. The company is uniquely positioned to integrate real-world clinical evidence with the latest advances in cancer genomics. H3 is developing a pipeline of highly targeted, breakthrough medicines that have the potential to impact the future of cancer care and treatment. The CEO of the company is Takashi Owa. | Health Technology |
- Beurs
- Insiders
- Terushige Iike
- Ervaring
